Publications by authors named "Tim L Beumer"

Claim this Profile
E
Effects on Spasticity and Neuropathic Pain of an Oral Formulation of Δ9-tetrahydrocannabinol in Patients WithProgressive Multiple Sclerosis.
Guido van Amerongen, Kawita Kanhai, Anne Catrien Baakman, Jules Heuberger, Erica Klaassen, Tim L Beumer

Clin Ther· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Population pharmacokinetic model of THC integrates oral, intravenous, and pulmonary dosing and characterizes short- and long-term pharmacokinetics.
Jules A A C Heuberger, Zheng Guan, Olubukayo-Opeyemi Oyetayo, Linda Klumpers, Paul D Morrison, Tim L Beumer

Clin Pharmacokinet· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel Δ(9) -tetrahydrocannabinol formulation Namisol® has beneficial pharmacokinetics and promising pharmacodynamic effects.
Linda E Klumpers, Tim L Beumer, Johan G C van Hasselt, Astrid Lipplaa, Lennard B Karger

Br J Clin Pharmacol· July 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The association between cytochrome P450 2D6 genotype and prescription patterns of antipsychotic and antidepressant drugs in hospitalized psychiatric patients: a retrospective follow-up study.
Hans Mulder, Frederik W Wilmink, Tim L Beumer, Wim J Tamminga, Jaap N Jedema

J Clin Psychopharmacol· April 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis